CA2701325A1 - Analysis of conjugated metabolites of alcohol consumption - Google Patents
Analysis of conjugated metabolites of alcohol consumption Download PDFInfo
- Publication number
- CA2701325A1 CA2701325A1 CA2701325A CA2701325A CA2701325A1 CA 2701325 A1 CA2701325 A1 CA 2701325A1 CA 2701325 A CA2701325 A CA 2701325A CA 2701325 A CA2701325 A CA 2701325A CA 2701325 A1 CA2701325 A1 CA 2701325A1
- Authority
- CA
- Canada
- Prior art keywords
- sample
- creatinine
- internal standard
- product
- deuterated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004458 analytical method Methods 0.000 title description 8
- 150000001298 alcohols Chemical class 0.000 title description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims abstract description 111
- 229940109239 creatinine Drugs 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 43
- 230000004149 ethanol metabolism Effects 0.000 claims abstract description 33
- 238000005259 measurement Methods 0.000 claims abstract description 23
- 230000004060 metabolic process Effects 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims description 72
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 210000002700 urine Anatomy 0.000 claims description 29
- IWJBVMJWSPZNJH-UQGZVRACSA-N ethyl glucuronide Chemical group CCO[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O IWJBVMJWSPZNJH-UQGZVRACSA-N 0.000 claims description 18
- KIWBPDUYBMNFTB-UHFFFAOYSA-M ethyl sulfate Chemical group CCOS([O-])(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-M 0.000 claims description 14
- 241000124008 Mammalia Species 0.000 claims description 10
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical group CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 238000003908 quality control method Methods 0.000 claims description 4
- 239000012470 diluted sample Substances 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 239000002207 metabolite Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 8
- 235000020095 red wine Nutrition 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 235000013334 alcoholic beverage Nutrition 0.000 description 5
- 235000015095 lager Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000013405 beer Nutrition 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 3
- 239000012482 calibration solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930182480 glucuronide Natural products 0.000 description 3
- 150000008134 glucuronides Chemical class 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 229940116674 robitussin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 125000004431 deuterium atom Chemical group 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000005040 ion trap Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000009428 plumbing Methods 0.000 description 2
- 235000020043 port wine Nutrition 0.000 description 2
- RRLOOYQHUHGIRJ-UHFFFAOYSA-M sodium;ethyl sulfate Chemical compound [Na+].CCOS([O-])(=O)=O RRLOOYQHUHGIRJ-UHFFFAOYSA-M 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- LFQSCWFLJHTTHZ-ZBJDZAJPSA-N 1,1,2,2,2-pentadeuterioethanol Chemical compound [2H]C([2H])([2H])C([2H])([2H])O LFQSCWFLJHTTHZ-ZBJDZAJPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 1
- 235000020284 irish coffee Nutrition 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 238000002552 multiple reaction monitoring Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020007 pale lager Nutrition 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 235000020092 scotch whiskey Nutrition 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000020046 sherry Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 235000013529 tequila Nutrition 0.000 description 1
- 235000012167 tiramisu Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/98—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving alcohol, e.g. ethanol in breath
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/466—Flow patterns using more than one column with separation columns in parallel
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/18—Sulfur containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
- Y10T436/204165—Ethanol
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97653907P | 2007-10-01 | 2007-10-01 | |
| US60/976,539 | 2007-10-01 | ||
| PCT/CA2008/001728 WO2009043149A1 (en) | 2007-10-01 | 2008-09-29 | Analysis of conjugated metabolites of alcohol consumption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2701325A1 true CA2701325A1 (en) | 2009-04-09 |
Family
ID=40508821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2701325A Abandoned CA2701325A1 (en) | 2007-10-01 | 2008-09-29 | Analysis of conjugated metabolites of alcohol consumption |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090087913A1 (enExample) |
| EP (1) | EP2208074A4 (enExample) |
| JP (1) | JP2010540911A (enExample) |
| CA (1) | CA2701325A1 (enExample) |
| WO (1) | WO2009043149A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200538738A (en) | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| EP2753707A4 (en) | 2011-09-08 | 2015-03-04 | Univ California | METABOLIC FLOW MEASUREMENT, IMAGING AND MICROSCOPY |
| ES2668678T3 (es) * | 2011-12-07 | 2018-05-21 | Glaxosmithkline Llc | Procedimiento de determinación de la masa muscular esquelética corporal total |
| RU2617400C2 (ru) | 2012-06-13 | 2017-04-24 | Асахи Касеи Кабусики Кайся | Способ детекции специфического вещества в молоке |
| US9134319B2 (en) | 2013-03-15 | 2015-09-15 | The Regents Of The University Of California | Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo |
| GB2512120A (en) * | 2013-03-21 | 2014-09-24 | Dario Veretnik | A novel Medical Device and Methods for determining Renal Function Levels in Mammals |
| WO2019232421A1 (en) * | 2018-06-01 | 2019-12-05 | Laboratory Corporation Of America Holdings | Methods and systems for lc-ms/ms proteomic genotyping |
| JP7380515B2 (ja) * | 2020-10-19 | 2023-11-15 | 株式会社島津製作所 | 質量分析を用いた試料分析方法及び試料分析システム |
| CN113533549B (zh) * | 2021-01-28 | 2023-05-12 | 岛津企业管理（中国）有限公司 | 白酒口味物质鉴定分析系统 |
| AU2022365434A1 (en) * | 2021-10-14 | 2024-05-02 | Owlstone Medical Limited | Method for the synthesis of evoc probes |
| CN114965810B (zh) * | 2022-05-16 | 2024-06-14 | 山西医科大学 | 一种推算饮酒时间的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3129250B2 (ja) * | 1997-09-10 | 2001-01-29 | 株式会社ミルス生命科学研究所 | 尿の化学分析方法 |
| US20060084134A1 (en) * | 2004-06-10 | 2006-04-20 | Wurst Friedrich M | Direct ethanol metabolite ethyl sulfate as an useful diagnostic and therapeutic marker of alcohol consumption |
| US20060160237A1 (en) * | 2004-12-06 | 2006-07-20 | Applera Corporation | Method of screening urine for organic acids |
| DK1875401T3 (da) * | 2005-06-30 | 2014-04-07 | Biocrates Life Sciences Ag | Indretning til kvantitativ analyse af en metabolitprofil |
| ES2392629T3 (es) * | 2006-03-02 | 2012-12-12 | Perkinelmer Health Sciences, Inc. | Métodos de distinción de isómeros mediante espectrometría de masas |
-
2008
- 2008-09-29 CA CA2701325A patent/CA2701325A1/en not_active Abandoned
- 2008-09-29 US US12/285,024 patent/US20090087913A1/en not_active Abandoned
- 2008-09-29 WO PCT/CA2008/001728 patent/WO2009043149A1/en not_active Ceased
- 2008-09-29 EP EP08800408A patent/EP2208074A4/en not_active Withdrawn
- 2008-09-29 JP JP2010526124A patent/JP2010540911A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010540911A (ja) | 2010-12-24 |
| EP2208074A1 (en) | 2010-07-21 |
| EP2208074A4 (en) | 2010-12-22 |
| US20090087913A1 (en) | 2009-04-02 |
| WO2009043149A1 (en) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090087913A1 (en) | Analysis of conjugated metabolites of alcohol consumption | |
| Chen et al. | Metabolome analysis for investigating host-gut microbiota interactions | |
| AU2020101064A4 (en) | High-throughput quantitation method for determination of free oligosaccharides in milk | |
| Wallace et al. | Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations | |
| Awwad et al. | Determination of trimethylamine, trimethylamine N-oxide, and taurine in human plasma and urine by UHPLC–MS/MS technique | |
| Liu et al. | Determination of polyamine metabolome in plasma and urine by ultrahigh performance liquid chromatography–tandem mass spectrometry method: Application to identify potential markers for human hepatic cancer | |
| Paull et al. | Evaluation of a novel method for the analysis of alcohol biomarkers: ethyl glucuronide, ethyl sulfate and phosphatidylethanol | |
| Andersson et al. | Analysis of urinary catecholamines: An improved auto-analyzer fluorescence method | |
| Rathkolb et al. | Clinical chemistry and other laboratory tests on mouse plasma or serum | |
| Kim et al. | A sensitive and specific liquid chromatography–tandem mass spectrometry method for the determination of intracellular and extracellular uric acid | |
| Jonklaas et al. | Total and free thyroxine and triiodothyronine: measurement discrepancies, particularly in inpatients | |
| Wilkinson et al. | Comparison of methods for the analysis of smoke related phenols and their conjugates in grapes and wine | |
| US20230282355A1 (en) | Integrated Biomarker System for Evaluating Risks of Impaired Fasting Glucose (IFG) and Type 2 Diabetes Mellitus (T2DM) | |
| Wu et al. | Urinary melamine and adult urolithiasis in Taiwan | |
| CN110618206A (zh) | 一种同时检测发酵食品中苯甲酸、山梨酸、糖精钠、苯乳酸、苯丙氨酸的方法 | |
| Tohmola et al. | Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors | |
| Wang et al. | Advancing towards practice: A novel LC-MS/MS method for detecting retinol in dried blood spots | |
| Toupin et al. | Analysis of globotriaosylceramide (Gb3) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometry | |
| CN111458417A (zh) | 联合检测待测样品中多种抗生素的方法及试剂盒 | |
| del Castillo et al. | Quantitative targeted biomarker assay for glycated haemoglobin by multidimensional LC using mass spectrometric detection | |
| Jiang et al. | Determination of molindone enantiomers in human plasma by high-performance liquid chromatography–tandem mass spectrometry using macrocyclic antibiotic chiral stationary phases | |
| Randell et al. | Changes in serum carbohydrate‐deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males | |
| Smy et al. | A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine | |
| US20250347694A1 (en) | Biological markers of liver fat | |
| CN117169408A (zh) | 一种同时检测水产品中9种糖苷类甜味剂的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20131001 |